Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis - Egidi, Maren Juliane; Krug, Sebastian; Haybäck, Johannes; Michl, Patrick; Griesmann, Heidi (British journal of cancer, 2023)